csjuarez

Would it be possible to interpret the 1+ reacton as Positive, but add a comment that the weak serological reaction (or molecular typing) indicate a probable Partial D and recommending the administration of Rh immune globulin during pregnancy?

We use the Soft LIS system. Our pre-admission outpatient specimens are extended for 14 days if the patient hasn't been pregnant or transfused in the last 3 months. We are able to update the expiration date for the sample in Patient -> Orders -> Modify when we are reviewing the patient's history and receiving the specimen in the Blood Bank. The expiration is automatically set at 3 days for all patients, so the tech receiving the specimen makes the change manually.

This checklist item has been recently revised. The note indicates "Laboratories must have a policy on how to handle truncated names on labels, if applicable." We are trying to determine the best way to handle this since with computer generated labels the full name is sometimes truncated, especially when the patient has a compound last name. I'd welcome any comments as to how your facility is handling it. Thanks!

I just answered this question. My Score PASS

I just answered this question. My Score PASS

I just answered this question. My Score PASS

I just answered this question. My Score FAIL

We had our Vision update a couple of weeks ago without a problem. There's some revalidation to do but it's relatively easy and went well. The instrument was unavailable for patient testing most of the day shift between the field engineer's work and our validation process.

I just answered this question. My Score FAIL

We were cited on the 30 minute rule at our last CAP inspection. We now rely on the temperature of the unit, taken with an infrared thermometer, if the unit is returned. The unit must register < 10C to be acceptable back into blood bank inventory. And we see, too, that the temperature can be out of range within a relatively short period of time.

I agree wholeheartedly with this! It's not what's done at my current lab (we do an IS XM with the gel XM), but it was the way I had implemented it at a previous blood bank. We had no issues with the inspections.

Congratulations! Enjoy your retirement years. I hope you do continue to monitor and participate in this forum as your knowledge and expertise are invaluable!

I used the Grifols Wadiana AKA Provue when I worked in Saudi Arabia for a few years. Wadiana & Provue are same instrument. In SA our reagents came through Diamed, so don't have any direct experience with Grifols or Erytra customer service or products.

I don't see any need to perform an antibody screen if only plasma is being transfused. ABO compatibility is the only requirement.

I can understand such a protocol if the backtype is undetectable and a coombs crossmatch is not otherwise required. However, if you are using a computer system for crossmatching, it should already have the protocols integrated to assure ABO compatability and such a serological protocol should only be needed during downtime.